New research from the Northwestern University Feinberg School of Medicine has found that an alternative therapy may be possible for treating some types of hypertension using an enzyme called ACE2. The research, conducted on mice in the laboratory of Daniel Batlle, M.D., professor of medicine at the Feinberg School and staff nephrologist at Northwestern Memorial Hospital, will appear in the January issue of Hypertension in a paper by lead author Jan Wysocki, a post-doctoral fellow in nephrology at the Feinberg School...
More...
More...